The effects of huperzine A on gastrointestinal acetylcholinesterase activity and motility after single and multiple dosing in mice

The acetylcholinesterase inhibitor (AChEI), huperzine A has been used in the treatment of the cognitive deterioration associated with Alzheimer’s disease (AD). However, the side-effects of huperzine A associated with increased cholinergic activity, particularly in the gastrointestinal system, are ev...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, LEIMING, SONG, YANQIN, LU, CHENGWEN, ZHANG, JIANQIAO, YUAN, JIANI, WANG, TIAN, FU, FENGHUA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570168/
https://www.ncbi.nlm.nih.gov/pubmed/23403922
http://dx.doi.org/10.3892/etm.2013.883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570168/
https://www.ncbi.nlm.nih.gov/pubmed/23403922
http://dx.doi.org/10.3892/etm.2013.883

Ejemplares similares